Cargando…

G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis

G protein-coupled receptor (GPR)35 is highly expressed in the gastro-intestinal tract, predominantly in colon epithelial cells (CEC), and has been associated with inflammatory bowel diseases (IBD), suggesting a role in gastrointestinal inflammation. The enterotoxigenic Bacteroides fragilis (ETBF) to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boleij, Annemarie, Fathi, Payam, Dalton, William, Park, Ben, Wu, Xinqun, Huso, David, Allen, Jawara, Besharati, Sepideh, Anders, Robert A., Housseau, Franck, Mackenzie, Amanda E., Jenkins, Laura, Milligan, Graeme., Wu, Shaoguang, Sears, Cynthia L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121840/ https://www.ncbi.nlm.nih.gov/pubmed/33990686 http://dx.doi.org/10.1038/s42003-021-02014-3

Ejemplares similares

2611. Enterotoxigenic Bacteroides fragilis Alters the Genome of Colon Epithelial Cells
por: Allen, Jawara, et al.
Publicado: (2019)

Isolation, Detection, and Characterization of Enterotoxigenic Bacteroides fragilis in Clinical Samples
por: Fathi, Payam, et al.
Publicado: (2016)

The Myeloid Immune Signature of Enterotoxigenic Bacteroides Fragilis-Induced Murine Colon Tumorigenesis
por: Orberg, Erik Thiele, et al.
Publicado: (2016)

Colon Tumors in Enterotoxigenic Bacteroides fragilis (ETBF)-Colonized Mice Do Not Display a Unique Mutational Signature but Instead Possess Host-Dependent Alterations in the APC Gene
por: Allen, Jawara, et al.
Publicado: (2022)

Genomic Diversity of Enterotoxigenic Strains of Bacteroides fragilis
por: Pierce, Jessica V., et al.
Publicado: (2016)

Enterotoxigenic and non-enterotoxigenic Bacteroides fragilis from fecal microbiota of children
por: Ignacio, Aline, et al.
Publicado: (2015)

Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis
por: Zamani, Samin, et al.
Publicado: (2017)

Complete Genome Sequence of an Enterotoxigenic Bacteroides fragilis Clinical Isolate
por: Nikitina, Anastasia S., et al.
Publicado: (2015)

Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A
por: Chan, June L., et al.
Publicado: (2018)

Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia
por: Purcell, Rachel V., et al.
Publicado: (2017)

Comparison of standard, quantitative and digital PCR in the detection of enterotoxigenic Bacteroides fragilis
por: Purcell, Rachel V., et al.
Publicado: (2016)

Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer
por: Oliero, Manon, et al.
Publicado: (2022)

Enterotoxigenic Bacteroides fragilis infection exacerbates tumorigenesis in AOM/DSS mouse model
por: Hwang, Soonjae, et al.
Publicado: (2020)

Designing a multi-epitopic vaccine against the enterotoxigenic Bacteroides fragilis based on immunoinformatics approach
por: Majid, Mahnoor, et al.
Publicado: (2019)

In Vitro Evaluation of the Therapeutic Potential of Phage VA7 against Enterotoxigenic Bacteroides fragilis Infection
por: Bakuradze, Nata, et al.
Publicado: (2021)

Role of Enterotoxigenic Bacteroides fragilis in Children Less Than 5 Years of Age With Diarrhea in Tabriz, Iran
por: Akhi, Mohammad Taghi, et al.
Publicado: (2016)

Enterotoxigenic Bacteroides fragilis: A Possible Etiological Candidate for Bacterially-Induced Colorectal Precancerous and Cancerous Lesions
por: Zamani, Samin, et al.
Publicado: (2020)

Enterotoxigenic Bacteroides fragilis activates IL-8 expression through Stat3 in colorectal cancer cells
por: Purcell, Rachel V., et al.
Publicado: (2022)

Repositioning small molecule drugs as allosteric inhibitors of the BFT‐3 toxin from enterotoxigenic Bacteroides fragilis
por: Jimenez‐Alesanco, Ana, et al.
Publicado: (2022)

GPR35 as a Novel Therapeutic Target
por: MacKenzie, A. E., et al.
Publicado: (2011)

Case-Control Study on the Role of Enterotoxigenic Bacteroides fragilis as a Cause of Diarrhea among Children in Kolkata, India
por: Ramamurthy, Dharanidharan, et al.
Publicado: (2013)

Enterotoxigenic Bacteroides fragilis induces the stemness in colorectal cancer via upregulating histone demethylase JMJD2B
por: Liu, Qian-Qian, et al.
Publicado: (2020)

Dietary Salt Administration Decreases Enterotoxigenic Bacteroides fragilis (ETBF)-Promoted Tumorigenesis via Inhibition of Colonic Inflammation
por: Hwang, Soonjae, et al.
Publicado: (2020)

Zerumbone Suppresses Enterotoxigenic Bacteroides fragilis Infection-Induced Colonic Inflammation through Inhibition of NF-κΒ
por: Hwang, Soonjae, et al.
Publicado: (2019)

Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait
por: Jamal, Wafaa, et al.
Publicado: (2020)

High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients
por: Khodaverdi, Nasibeh, et al.
Publicado: (2021)

Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer
por: Dadgar-Zankbar, Leila, et al.
Publicado: (2023)

Higher Prevalence of Bacteroides fragilis in Crohn’s Disease Exacerbations and Strain-Dependent Increase of Epithelial Resistance
por: Becker, Heike E. F., et al.
Publicado: (2021)

Interaction of Bacteroides fragilis and Bacteroides thetaiotaomicron with the kallikrein–kinin system
por: Murphy, Elizabeth C., et al.
Publicado: (2011)

Protective Effects of Zerumbone on Colonic Tumorigenesis in Enterotoxigenic Bacteroides fragilis (ETBF)-Colonized AOM/DSS BALB/c Mice
por: Hwang, Soonjae, et al.
Publicado: (2020)

Multidrug-Resistant Bacteroides fragilis — Seattle, Washington, 2013
por: Kalapila, Aley, et al.
Publicado: (2013)

Fecal Enterotoxigenic Bacteroides fragilis–Peptostreptococcus stomatis–Parvimonas micra Biomarker for Noninvasive Diagnosis and Prognosis of Colorectal Laterally Spreading Tumor
por: Shen, Xiaonan, et al.
Publicado: (2021)

Cellular immunity to Bacteroides fragilis capsular polysaccharide
Publicado: (1982)

Emergence of metronidazole-resistant Bacteroides fragilis, India.
por: Chaudhry, R, et al.
Publicado: (2001)

Bacteroides fragilis metabolises exopolysaccharides produced by bifidobacteria
por: Rios-Covian, David, et al.
Publicado: (2016)

Bacterial Pyomyositis in the Neck Due to Bacteroides Fragilis
por: Dalal, Kajal, et al.
Publicado: (2021)

The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015)

G Protein-Coupled Receptor GPR35 Suppresses Lipid Accumulation in Hepatocytes
por: Lin, Li-Chiung, et al.
Publicado: (2021)

G protein‐coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35
por: Milligan, Graeme
Publicado: (2017)

Early intestinal Bacteroides fragilis colonisation and development of asthma
por: Vael, Carl, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_7j6cuua1ihhaso9gthrvjeei2r